Kurs
0,00%
Kurs
0,00%
Kalender
Est. tid* | ||
2020-11-20 | - | Extra Bolagsstämma |
2015-12-09 | - | 15-6 2015 |
2015-09-21 | - | Extra Bolagsstämma 2015 |
2014-11-27 | - | Kvartalsrapport 2014-Q3 |
2014-08-28 | - | Kvartalsrapport 2014-Q2 |
2014-05-22 | - | Kvartalsrapport 2014-Q1 |
2014-02-27 | - | Bokslutskommuniké 2013 |
2013-11-28 | - | Kvartalsrapport 2013-Q3 |
2013-08-28 | - | Kvartalsrapport 2013-Q2 |
2013-06-11 | - | Årsstämma |
2013-05-21 | - | Kvartalsrapport 2013-Q1 |
2013-03-12 | - | Extra Bolagsstämma 2013 |
2013-02-28 | - | Bokslutskommuniké 2012 |
2012-11-28 | - | Kvartalsrapport 2012-Q3 |
2012-08-28 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | Årsstämma |
2012-05-30 | - | Kvartalsrapport 2012-Q1 |
2012-02-28 | - | Bokslutskommuniké 2011 |
2011-11-22 | - | Kvartalsrapport 2011-Q3 |
2011-08-31 | - | Kvartalsrapport 2011-Q2 |
2011-06-15 | - | Årsstämma |
2011-05-31 | - | Kvartalsrapport 2011-Q1 |
2011-02-28 | - | Bokslutskommuniké 2010 |
2020-11-05 15:13:13
The growth of the company continued in third quarter and reached 66,2 MNOK in sales Q3 2020
vs. 48,5 MNOK last year, which was a growth of + 36,3 % vs. Q3 last year.
YTD (Jan-Sept) 2020 the company reached a turnover of 183 MNOK vs. 139 MNOK last year, which is a growth of 31,8 % in turnover so far this year.
In Q3, the company continued its focus on innovation and development of test based health concepts, and launched a new combined test kit of measuring Vitamin K2 and Vitamin D levels in the blood in combination with the use of our premium Vitamin K2/D3 product.
For questions, contact:
Roar Arnstad
CEO
E-mail: roar.arnstad@eqology.no
Christian Espeseth
Chairman of the board